Cellectis SA
- Biotech or pharma, therapeutic R&D
Cellectis is a biopharmaceutical company focused on gene editing and on the development of cancer immunotherapies based on allogeneic CAR T-cells (UCART).
June 16-19, 2025
Boston Convention & Exhibition Center